Jushi Holdings (JUSHF) Assets Average (2022 - 2026)
Jushi Holdings' (JUSHF) quarterly Assets Average came in at $428.7 million in Q1 2026, down 1.88% year-on-year from $437.0 million in Q1 2025, and little changed on a QoQ basis from $427.0 million in Q4 2025.
Jushi Holdings (JUSHF) Assets Average (2022 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 5 years of Assets Average data on file, last reported at $428.7 million in Q1 2026.
- On a quarterly basis, Assets Average fell 1.88% year-over-year to $428.7 million in Q1 2026; TTM through Mar 2026 was $428.7 million, a 1.88% decrease from a year earlier, with the FY2025 full-year figure at $431.3 million, down 4.54% from the prior year.
- Assets Average for Q1 2026 stood at $428.7 million, roughly flat from $427.0 million in the prior quarter.
- Over the last five years, Assets Average for JUSHF reached as high as $688.1 million in Q3 2022 and fell as low as $427.0 million in Q4 2025.
- Historically, Assets Average has averaged $505.8 million across 5 years, with a median of $460.6 million in 2024.
- Across the five-year window, Assets Average declined 28.05% in 2023 and retreated 1.88% in 2026, its largest moves.
- Year by year, Assets Average stood at $597.4 million in 2022, then slipped by 20.31% to $476.0 million in 2023, then fell by 7.29% to $441.3 million in 2024, then decreased by 3.24% to $427.0 million in 2025, then advanced by 0.4% to $428.7 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $428.7 million in Q1 2026, $427.0 million in Q4 2025, and $432.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 428.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 428.74 Mn |
| Dec 31, 2025 | 427.02 Mn |
| Sep 30, 2025 | 432.03 Mn |
| Jun 30, 2025 | 432.99 Mn |
| Mar 31, 2025 | 436.97 Mn |
| Dec 31, 2024 | 441.32 Mn |
| Sep 30, 2024 | 448.78 Mn |
| Jun 30, 2024 | 456.54 Mn |
| Mar 31, 2024 | 460.62 Mn |
| Dec 31, 2023 | 476.03 Mn |
| Sep 30, 2023 | 495.08 Mn |
| Jun 30, 2023 | 510.76 Mn |
| Mar 31, 2023 | 524.69 Mn |
| Dec 31, 2022 | 597.38 Mn |
| Sep 30, 2022 | 688.09 Mn |
| Jun 30, 2022 | 685.16 Mn |
| Mar 31, 2022 | 655.80 Mn |